Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma.
Smith LK, Parmenter T, Kleinschmidt M, Kusnadi EP, Kang J, Martin CA, Lau P, Patel R, Lorent J, Papadopoli D, Trigos A, Ward T, Rao AD, Lelliott EJ, Sheppard KE, Goode D, Hicks RJ, Tiganis T, Simpson KJ, Larsson O, Blythe B, Cullinane C, Wickramasinghe VO, Pearson RB, McArthur GA.
Smith LK, et al. Among authors: kusnadi ep.
Nat Commun. 2022 Mar 1;13(1):1100. doi: 10.1038/s41467-022-28705-x.
Nat Commun. 2022.
PMID: 35232962
Free PMC article.